Clinical trial
The Effects of GSK2586881 on the Responses to Acute Hypoxia and Exercise
NCT03000686 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of GSK2586881 on the Responses to Acute Hypoxia and Exercise
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- May 17, 2017
- Completion date
- January 4, 2019
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers